MicroSynbiotiX

Microalgae synthetic biology company: A platform for oral delivery of vaccines to animals

Company Details

Aquaculture is the future of sustainable food production. It is the world's fastest growing food sector, with an estimated worth of 200 billion USD, but every year, farmers face a crisis with managing disease, losing more than 10 billion USD worth of fish stocks annually. MicroSynbiotiX is developing cost-effective oral vaccines to combat these infections and improve global food security. We are developing a novel, patent-pending method of producing oral vaccines using transgenic microalgae. Our solution will make disease management much more sustainable and reduce the need for antibiotics.

  • MicroSynbiotiX- oral drug delivery technology

Company People

Antonio Lamb

Antonio Lamb
COO & Co-Founder

Simon Jegan

Simon Jegan
CEO & Co-Founder

MicroSynbiotiX News

VIEW ALL

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision.  Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.